Epstein-Barr-Virus-Positive B-Cell Lymphoma of Recipient Origin Despite of the Elimination of Clonally EBV-Infected T Cells by Allogeneic Stem Cell Transplantation in a Patient with Chronic Active EBV Infection
Figure 2
Brain MRI of the patient. Initial frontal tumor that was surrounded by T2 high edematous area disappeared completely on the 294th day, but right paraventricular tumor grew progressively.